C

Cleveland Clinic | Cole Eye Institute

Research site
(Unclaimed)
Location
2022 E 105th Street, Cleveland, Ohio, United States of America

Site insights

Top conditions

Top treatments

Fluocinolone Acetonide
AU-011
Kenalog
triamcinolone acetonide

Parent organization

This site is a part of Cleveland Clinic

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 5 total trials

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma (CoMpass)

The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary i...

Enrolling
Indeterminate Lesions
Ocular Melanoma
Device: Suprachoroidal Microinjector
Drug: Sham Treatment

Trial sponsors

NeuroTherapia, Inc. logo
A
Aura Biosciences logo
National Institutes of Health (NIH) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems